A new method has been established for the simultaneous estimation of Telmisartan and Atorvastatin calcium by RP-HPLC method. The chromatographic conditions were successfully developed for the separation of Telmisartan and Atorvastatin calcium by using boston ODS C18 column, flow rate was 1.0ml/min, mobile Phase consists of methanol:Acetonitrile:buffer in ratio of 35:25:40. Detection wave length was 235nm.The instrument used was SHIMADZU HPLC auto sampler. The retention time of Atorvastatin calcium and Telmisartan was found to be 2.350 and 3.490 minutes respectively. The analytical method was validated according to ICH guidelines (ICH Q2b). The correlation coefficient (r 2 ) was found to be 0.997 and 0.999 for Telmisartan and Atorvastatin calcium respectively. % mean recovery was found to be 100.943% and 100.576% for Telmisartan and Atorvastatin calcium respectively. %RSD for precision on replicate injection was 0.46 and 0.70 for Telmisartan and Atorvastatin calcium respectively. The validation study was found to be precise, robust, and repeatable.
INTRODUCTION Telmisartan
Telmisartan is an orally active non peptide Angiotensin ІІ antagonist that acts on the AT1 receptor subtype. Telmisartan interferes with the binding of angiotensin II to the angiotensin II AT1-receptor by binding reversibly and selectively to the receptors in vascular smooth muscle and the adrenal gland. As angiotensin II is a vasoconstrictor, which also stimulates the synthesis and release of aldosterone, blockage of its effects results in decreases in systemic vascular resistance. Telmisartan does not inhibit the angiotensin converting enzyme, other hormone receptors, or ion channels [1] [2] [3] . 
carbonyl]-lH-pyrrole-1-heptanoic acid, calcium salt, is a synthetic cholesterol-lowering agent1. Atorvastatin calcium selectively and competitively inhibits the hepatic Hydroxy methyl glutaryl-coenyme A (HMG-CoA) reductase, the ratedetermining enzyme located in hepatic tissue that produces mevalonate, a small molecule used in the synthesis of cholesterol and other mevalonate derivatives. This lowers the amount of cholesterol produced which in turn lowers the total amount of LDL cholesterol. [4] [5] [6] The detection wavelength was selected by dissolving Telmisartan and Atorvastatin calcium in diluent to get concentration of the 10 g/ml. The resulting solution was scanned in U.V range from 200-400nm. The absorbance maximum was found to be 235nm. The chromatographic method development for the estimation of Telmisartan and Atorvastatin calcium were optimized by several trials for various parameters as different column, flow rate and mobile phase, finally the following chromatographic method was selected for the separation and quantification of Telmisartan and Atorvastatin calcium in API and pharmaceutical dosage form by RP-HPLC.
Preparation of solutions for optimized conditions of method validation 8-10 :
Buffer Preparation:
1.3609 gm of Potassium di-hydrogen phosphate was added in sufficient water to produce 1000ml, pH adjusted to 4.5 with orthophosphoric acid.
Solvent mixture:
Prepare mixture of methanol, acetonitrile and buffer in ratio of 35:25:40v/v respectively.
Mobile phase:
Prepare a filtered (0.45µ) and degassed mixture of methanol, acetonitrile and buffer preparation in ratio of 35:25:40v/v respectively. 
Linearity:
The linearity study was performed for the concentration of 60ppm to 140ppm level. Each level was injected into chromatographic system the area of each level was used for calculation of correlation coefficient. The linearity study was performed and the correlation coefficient of Telmisartan and Atorvastatin calcium was found to be 0.999 and 0.997 respectively (NMT 0.999). 
ISSN

Precision:
The precision study was performed for six injections of Telmisartan and Atorvastatin calcium. Each standard was injected into chromatographic system. The area of each standard injection was used for calculation of %RSD. Robustness:
Chromatographic conditions variation:
To demonstrate the robustness of the method, prepared solution as per test method are injected at different variable conditions like using different conditions like flow rate and wavelength. System suitability parameters were compared with that of method precision. 
Ruggedness:
Ruggedness of the method was studied by determining the analyst to analyst variation by performing the Assay by two different analysts 
